News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Liberty Energy announced a $500 million convertible-note offering, sending its shares down about 3.3% in premarket trading.
  • Palantir posted strong results and aggressive 2026 guidance, pushing the stock sharply higher and prompting calls for a re-rating.
  • Daiwa upgraded Mastercard and Visa to Outperform after quarter beats, signaling reduced uncertainty in payments earnings.
  • Arko Petroleum filed to raise up to $210 million in an IPO that could value the business near $1 billion while Arko Corp keeps control.
  • USTR Jamieson Greer said the Supreme Court is moving deliberately on the challenge to Trump-era tariffs, underscoring legal uncertainty for tariff revenue.
  • Nukkleus's subsidiary won about $4.1 million in multi-year Israeli defense contracts, lifting the parent stock roughly 4% premarket.

Latest Articles

Euro zone closes 2025 on steady footing as domestic demand offsets weak exports

Euro zone closes 2025 on steady footing as domestic demand offsets weak exports

National data released on Friday show the euro zone's largest economies delivered modest but consistent expansion in the final quarter of 2025. Stronger household spending and business investment helped compensate for sluggish exports and lingering uncertainty from U.S. trade policy. Early 2026 indicators point to continued resilience, while struct…

Scatec Reports Q4 Shortfall on Consolidated Metrics, Backlog Expands Sharply

Scatec Reports Q4 Shortfall on Consolidated Metrics, Backlog Expands Sharply

Scatec posted fourth-quarter consolidated results that fell short of analyst expectations, with revenue and EBITDA declining year-on-year and quarter-on-quarter. On a proportionate basis, power production and Power Production EBITDA were roughly in line with forecasts, and Development & Construction delivered materially stronger EBITDA than anticip…

Jefferies Starts Coverage on Engene, Assigns Buy and $28 Target

Jefferies Starts Coverage on Engene, Assigns Buy and $28 Target

Jefferies has launched coverage of Engene Holdings Inc. (ENGN) with a Buy rating and a $28 price target, implying roughly 173% upside from the stock's current level of $10.27. The firm highlights Engene's ongoing pivotal study in high-risk non-muscle invasive bladder cancer (HR-NMIBC), a key data update expected in the second half of 2026, and favo…

European Stocks Tick Up as Earnings Strength Counters Geopolitical Caution

European Stocks Tick Up as Earnings Strength Counters Geopolitical Caution

European equities advanced modestly on Friday as investors balanced upbeat corporate results against persistent geopolitical and trade concerns. The STOXX 600 rose 0.1% by 0804 GMT and was poised for a 2.6% gain for January if current levels held, marking a seventh consecutive monthly increase - the longest run since 2021. Market participants noted…

Citizens Lowers SAP Rating to Market Perform After Weak Q4; Shares Retreat

Citizens Lowers SAP Rating to Market Perform After Weak Q4; Shares Retreat

Citizens has cut its rating on SAP from Market Outperform to Market Perform following a set of fourth-quarter results that mixed an above-consensus non-IFRS EPS and operating profit with revenue and cloud metrics that fell short of expectations. The stock has seen significant recent volatility, trading near $200 and sliding sharply in the week afte…

Bernstein Identifies European Medical Technology Stocks Set to Lead in 2026

Bernstein Identifies European Medical Technology Stocks Set to Lead in 2026

Bernstein's recent analysis singles out ten European medical technology companies with differentiated pathways to stronger performance in 2026. The list spans dental specialists, biomanufacturing suppliers, diagnostics and hearing-aid leaders. Key drivers cited include end-market recoveries, product cycles, margin mix improvements, capacity moves a…

Avio Lifts 2025 Revenue Forecast After Strong Q4 Commercial Push

Avio Lifts 2025 Revenue Forecast After Strong Q4 Commercial Push

Avio SpA updated its full-year 2025 outlook, citing robust commercial momentum in the fourth quarter and quicker-than-expected contract execution. The company raised its projected order backlog and group revenue ranges, reported a net cash position approaching €600 million, and left profit and EBITDA guidance intact.

Drax secures 10-year tolling contract for 250MW (500MWh) battery storage

Drax secures 10-year tolling contract for 250MW (500MWh) battery storage

Drax has entered a 10-year tolling agreement with West Burton C Limited, owned by Fidra Energy, for 250MW (500MWh) of battery energy storage capacity. Fidra will finance construction, provide maintenance and guarantee availability with no upfront capital outlay from Drax. Under the contract Drax will pay an annual tolling fee indexed to UK CPI, gai…

Tetragon Posts Essentially Flat Year-End NAV After Mixed Portfolio Moves

Tetragon Posts Essentially Flat Year-End NAV After Mixed Portfolio Moves

Tetragon Financial Group reported a diluted net asset value (NAV) per share of $41.88 as of December 31, 2025, a 0.1% increase for the month. For the full year 2025 the investment company recorded a NAV total return of 19.6%. Under the surface, portfolio-level write-downs to LCM and Ripple were largely counterbalanced by a modest write-up to Equiti…

Recordati and Moderna Team Up to Advance mRNA Therapy for Propionic Acidemia

Recordati and Moderna Team Up to Advance mRNA Therapy for Propionic Acidemia

Recordati has entered a strategic collaboration with Moderna to develop and commercialize mRNA-3927 for propionic acidemia (PA). The deal includes a $50 million upfront payment, up to $110 million in near-term milestone payments, and tiered royalties, while pivotal data are expected by the end of 2026. Recordati says material EBITDA effects are not…

Stelrad Posts Profit Gain as Margins Offset Volume Weakness

Stelrad Posts Profit Gain as Margins Offset Volume Weakness

Stelrad Group reported a rise in adjusted operating profit for the year ended December 31, 2025, underpinned by margin management, cost reductions and a stronger mix, even as volumes fell 4% year-on-year. Revenue was about £280 million, adjusted operating profit rose to approximately £32.5 million and net debt before lease liabilities fell to £51.2…

Jones Trading Starts Coverage of RenovoRx, Issues Buy Rating and $8 Target

Jones Trading Starts Coverage of RenovoRx, Issues Buy Rating and $8 Target

Jones Trading has begun coverage of RenovoRx Inc. (RNXT) with a Buy rating and an $8.00 price objective, implying substantial upside from the stock's current trading level of $0.96. Data from InvestingPro highlighted valuation metrics, balance-sheet strength and clinical development milestones, while the company’s most recent quarterly report recor…